Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

Similar articles for PubMed (Select 24116237)

1.

Correction: The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression.

Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK.

PLoS One. 2013 Sep 30;8(9). doi: 10.1371/annotation/9ae8db84-5d44-4a9c-bb80-47c9d68820ea. eCollection 2013.

2.

Erratum: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

Kong D, Heath E, Chen W, Cher M, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr W, Menon M, Sarkar F.

Am J Transl Res. 2013 Dec 1;6(1):102-103. eCollection 2013.

3.

MicroRNA expression and clinical outcome of small cell lung cancer.

Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G.

PLoS One. 2011;6(6):e21300. doi: 10.1371/journal.pone.0021300. Epub 2011 Jun 22.

4.

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

Carcinogenesis. 2009 Nov;30(11):1903-9. doi: 10.1093/carcin/bgp219. Epub 2009 Sep 7.

5.

MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer.

Peurala H, Greco D, Heikkinen T, Kaur S, Bartkova J, Jamshidi M, Aittomäki K, Heikkilä P, Bartek J, Blomqvist C, Bützow R, Nevanlinna H.

PLoS One. 2011;6(11):e26122. doi: 10.1371/journal.pone.0026122. Epub 2011 Nov 10.

6.

microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.

Wang X, Dong K, Gao P, Long M, Lin F, Weng Y, Ouyang Y, Ren J, Zhang H.

Cancer Biother Radiopharm. 2013 Feb;28(1):45-50. doi: 10.1089/cbr.2012.1218. Epub 2012 Oct 4.

PMID:
23036084
7.

Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.

Cao W, Fan R, Wang L, Cheng S, Li H, Jiang J, Geng M, Jin Y, Wu Y.

Tumour Biol. 2013 Apr;34(2):963-71. doi: 10.1007/s13277-012-0632-8. Epub 2012 Dec 22.

PMID:
23264087
8.

Expression and role of miR-34a in bladder cancer.

Wang W, Li T, Han G, Li Y, Shi LH, Li H.

Indian J Biochem Biophys. 2013 Apr;50(2):87-92.

PMID:
23720881
9.

MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.

Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS.

Carcinogenesis. 2010 Jun;31(6):1037-44. doi: 10.1093/carcin/bgq066. Epub 2010 Mar 29.

10.

Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer.

Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T, Hermeking H.

Clin Cancer Res. 2013 Feb 1;19(3):710-20. doi: 10.1158/1078-0432.CCR-12-1703. Epub 2012 Dec 14.

11.

Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer.

Franchina T, Amodeo V, Bronte G, Savio G, Ricciardi GR, Picciotto M, Russo A, Giordano A, Adamo V.

J Cell Physiol. 2014 Jan;229(1):97-9. doi: 10.1002/jcp.24422.

PMID:
23794259
12.

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

de Antonellis P, Medaglia C, Cusanelli E, Andolfo I, Liguori L, De Vita G, Carotenuto M, Bello A, Formiggini F, Galeone A, De Rosa G, Virgilio A, Scognamiglio I, Sciro M, Basso G, Schulte JH, Cinalli G, Iolascon A, Zollo M.

PLoS One. 2011;6(9):e24584. doi: 10.1371/journal.pone.0024584. Epub 2011 Sep 12.

13.

The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.

Wang M, Zhang P, Li Y, Liu G, Zhou B, Zhan L, Zhou Z, Sun X.

Med Oncol. 2012 Dec;29(5):3113-8. doi: 10.1007/s12032-012-0241-9. Epub 2012 May 5.

PMID:
22562822
14.

Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.

Rücker FG, Russ AC, Cocciardi S, Kett H, Schlenk RF, Botzenhardt U, Langer C, Krauter J, Fröhling S, Schlegelberger B, Ganser A, Lichter P, Zenz T, Döhner H, Döhner K, Bullinger L.

Leukemia. 2013 Feb;27(2):353-61. doi: 10.1038/leu.2012.208. Epub 2012 Jul 19.

PMID:
22810507
15.
16.

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.

Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H.

Oncogene. 2011 Jun 23;30(25):2888-99. doi: 10.1038/onc.2011.13. Epub 2011 Feb 14.

PMID:
21317930
17.

MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.

Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF.

Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22.

18.

miRNA-34a is associated with docetaxel resistance in human breast cancer cells.

Kastl L, Brown I, Schofield AC.

Breast Cancer Res Treat. 2012 Jan;131(2):445-54. doi: 10.1007/s10549-011-1424-3. Epub 2011 Mar 12.

PMID:
21399894
19.

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.

Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM.

PLoS One. 2015 Jun 25;10(6):e0131729. doi: 10.1371/journal.pone.0131729. eCollection 2015.

20.

Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.

Kashat M, Azzouz L, Sarkar SH, Kong D, Li Y, Sarkar FH.

Am J Transl Res. 2012;4(4):432-42. Epub 2012 Oct 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk